.png){kind=logo}
Pharmaceuticals
Win-Medicare Pvt. Ltd.
In India’s dynamic and highly competitive pharmaceutical landscape, Win-Medicare has carved a distinctive place as a trusted, innovation-led healthcare company. Guided by a commitment to excellence, the company is driven by the mission to elevate healthcare standards and improve lives.
At the heart of this vision is Betadine® (licensed from Mundipharma, Switzerland) — the flagship brand that has defined antiseptic care for decades. Revered by healthcare professionals in over 75 countries, Betadine® remains the undisputed leader in the PVPI (Povidone-Iodine) segment, delivering reliable, broad-spectrum antiseptic efficacy that inspires trust. Today, Win-Medicare is among India’s fastest-growing pharmaceutical companies, with a robust presence at home and a growing footprint across Asia and Africa. Powered by three state-of-the-art manufacturing plants and an expansive distribution network, the company offers a diverse portfolio of world-class brands across multiple therapy areas:
-
Antiseptics - Betadine® (Mundipharma, Switzerland)
-
Hepatology - HepaMerz® (Merz Pharma, Germany)
-
Scar Management - Contractubex® – (Merz Pharma, Germany)
-
Urology - Evafos® (Zambon, Italy)
-
Gastroenterology - Movicol® (Norgine, Netherlands)
-
Footcare - Once Heal Balm from Dermatonics (UK)
Through innovation, trusted partnerships, and an unwavering dedication to quality, Win-Medicare continues to shape the future of healthcare.
Win-Medicare Product Range
Anti-Bribery & Corruption
Policy
Compliance Hotline Email id :
compliance.complaint@modimundipharma.com
Anti-Bribery & Corruption Policy
Compliance Hotline Email id : compliance.complaint@modimundipharma.com
Modi-Mundipharma Pvt Ltd.
The Umesh Modi Group forged a landmark joint venture in 1990 with the Mundipharma Group of Switzerland, giving rise to Modi-Mundipharma Pvt. Ltd. This strategic alliance marked a pivotal step in expanding the Group’s footprint in the pharmaceutical sector, reinforcing its commitment to delivering cutting-edge healthcare solutions to the Indian market. Over the years, Modi-Mundipharma has grown into a dynamic pharmaceutical company, known for combining international innovation with local expertise. It draws its strength from the research and formulation excellence of its global affiliates—Mundipharma AG (Switzerland), Napp Pharmaceutical Group (UK), and The Purdue Frederick Company (USA)—renowned for their novel drug delivery systems and advanced manufacturing capabilities.
A key differentiator for Modi-Mundipharma is its focus on long-acting formulations, particularly through the proprietary Continus® Technology, which enhances drug efficacy and patient compliance. Flagship brands such as Nitrocontin® and Unicontin-E® have earned the trust of medical professionals across India. To further drive innovation and local development, a state-of-the-art R&D Centre was established in India in 2001.
In-Licensing Agreements
The company offers a broad therapeutic portfolio spanning Cardiology, Gynaecology, Urology, Respiratory care, Pain Management, making it a comprehensive healthcare provider. In addition, Modi-Mundipharma has forged valuable in-licensing and distribution agreements with leading global pharmaceutical companies, further strengthening its product offerings and market presence. Modi-Mundipharma markets the following mentioned key brands:
-
Cardiology - Nitrocontin and Unicontin from Mundipharma
-
Pain Management - Buvalor from Mundipharma
-
Scar Management - Xeomin (Merz Pharma, Germany)
-
Respiratory - Fluimucil (Zambon,Italy)
-
Urology - Monurol (Zambon,Italy)
-
Orthopaedics - Monovisc and Cingal (Anika Therapeutics, USA)
-
Oncology - Navelbine from Pirre Fabre, France
With a strong presence across India and growing operations in Asia and Africa, Modi-Mundipharma continues to introduce differentiated, high-tech pharmaceutical solutions. This joint venture stands as a testament to the Umesh Modi Group’s vision of elevating healthcare standards through global collaborations and scientific excellence.
Modi-Mundipharma Product Range
Anti-Bribery & Corruption
Policy
Compliance Hotline Email id :
compliance.complaint@modimundipharma.com
Anti-Bribery & Corruption Policy
Compliance Hotline Email id : compliance.complaint@modimundipharma.com
Win-Healthcare
Established in the year 2005 as a strategic business unit of Win-Medicare Pvt. Ltd., Win Healthcare focuses on marketing and distribution of OTC healthcare products in India. The company is committed to offering well-differentiated, globally trusted brands that address everyday health and wellness needs. Its flagship product, Mederma® (for more info visit www.mederma.co.in) from Perrigo, Ireland, is a market leader in the anti-scar segment and is available in more than 100,000 retail outlets in India. Win Healthcare also markets Jungle Formula® – an international mosquito repellent brand, Pheet footcare brand from Dermatonics (UK) and Physiomer® – a natural nasal care solution.
With a strong distribution network spanning pharmacies, modern trade, and general retail, Win Healthcare is steadily expanding its footprint. The company is poised for growth, backed by a portfolio of innovative, high-quality products that are reshaping self-care in India.
With a strong distribution network covering pharmacies, modern trade, and general retail, Win Healthcare is steadily expanding its footprint. The company is poised for growth, backed by a portfolio of innovative, high-quality products that are reshaping self-care in India.
.jpg)
Win-Healthcare Product Range
Anti-Bribery & Corruption Policy
Compliance Hotline Email id : compliance.complaint@modimundipharma.com